← FDA DRUG APPROVALS

FDA ANDA · ANDA075225

ISOFLURANE

Sponsor: HALOCARBON PRODS

APPLICATION
ANDA075225
TYPE
ANDA
ORIGINAL APPROVAL
1999-10-20
LATEST ACTION
2020-09-23
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
LIQUID
MARKETING STATUS
Prescription

Products

ISOFLURANEPrescription
ISOFLURANE 99.9% · LIQUID · INHALATION

Approval history

2020-09-23Labeling · Supplement 6 · standardAP
1999-10-20OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →